Michelle Letarte - Publications

University of Toronto, Toronto, ON, Canada 
Cell Biology, Molecular Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Cheng KH, Mariampillai A, Lee KK, Vuong B, Luk TW, Ramjist J, Curtis A, Jakubovic H, Kertes P, Letarte M, Faughnan ME, Yang VX. Histogram flow mapping with optical coherence tomography for in vivo skin angiography of hereditary hemorrhagic telangiectasia. Journal of Biomedical Optics. 19: 086015. PMID 25140883 DOI: 10.1117/1.JBO.19.8.086015  0.48
2011 Al-Saleh S, John PR, Letarte M, Faughnan ME, Belik J, Ratjen F. Symptomatic liver involvement in neonatal hereditary hemorrhagic telangiectasia. Pediatrics. 127: e1615-20. PMID 21536610 DOI: 10.1542/peds.2010-2366  0.48
2006 Mei-Zahav M, Letarte M, Faughnan ME, Abdalla SA, Cymerman U, MacLusky IB. Symptomatic children with hereditary hemorrhagic telangiectasia: a pediatric center experience. Archives of Pediatrics & Adolescent Medicine. 160: 596-601. PMID 16754821 DOI: 10.1001/archpedi.160.6.596  0.48
2005 Cohen JH, Faughnan ME, Letarte M, Vandezande K, Kennedy SJ, Krahn MD. Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. American Journal of Medical Genetics. Part A. 137: 153-60. PMID 16059938 DOI: 10.1002/ajmg.a.30838  0.48
2004 Chan NL, Bourdeau A, Vera S, Abdalla S, Gross M, Wong J, Cymerman U, Paterson AD, Mullen B, Letarte M. Umbilical vein and placental vessels from newborns with hereditary haemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin. Placenta. 25: 208-17. PMID 14972453 DOI: 10.1016/S0143-4004(03)00181-4  0.48
2001 Cho SK, Bourdeau A, Letarte M, Zúñiga-Pflücker JC. Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. Blood. 98: 3635-42. PMID 11739167  0.48
2001 Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR, Letarte M. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. The American Journal of Pathology. 158: 2011-20. PMID 11395379  0.48
2000 Bourdeau A, Faughnan ME, Letarte M. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. Trends in Cardiovascular Medicine. 10: 279-85. PMID 11343967  0.48
2000 Matsubara S, Bourdeau A, terBrugge KG, Wallace C, Letarte M. Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Stroke; a Journal of Cerebral Circulation. 31: 2653-60. PMID 11062290  0.48
2000 Bourdeau A, Cymerman U, Paquet ME, Meschino W, McKinnon WC, Guttmacher AE, Becker L, Letarte M. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. The American Journal of Pathology. 156: 911-23. PMID 10702408 DOI: 10.1016/S0002-9440(10)64960-7  0.48
2000 Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI, Dunn J, Letarte M. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatric Research. 47: 24-35. PMID 10625079  0.48
1999 Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. The Journal of Clinical Investigation. 104: 1343-51. PMID 10562296 DOI: 10.1172/JCI8088  0.48
1997 Pichuantes S, Vera S, Bourdeau A, Pece N, Kumar S, Wayner EA, Letarte M. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens. 50: 265-76. PMID 9331949  0.48
Show low-probability matches.